ArticleOncogene2022

A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer.

Malene Blond Ipsen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.